3 trial tables · Checked
TRIUMPH-1
In TRIUMPH-1, 4.1% to 11.3% on retatrutide (by dose) had stopped treatment because of side effects. On placebo, 4.9% did.
See all 3 tablesFrom the label: more on stopped because of side effects
Each dot is 1 in 100 people.
Reported it Rest of a dose range Did not report it
Filled dots show the low end of a range. Dots are rounded. The exact number is above each grid.
RetatrutideNo FDA-approved product
Row in the source: Stopped treatment because of side effects
RetatrutideNo FDA-approved product
Row in the source: Stopped treatment because of side effects
RetatrutideNo FDA-approved product
Row in the source: Stopped treatment because of side effects
These lines are copied from our side effect pages, word for word.
6.2% of adults on Saxenda stopped because of these problems, compared with 0.8% on placebo. In the Victoza trials, 4.3% stopped for these reasons, compared with 0.5% on placebo. Most of these Victoza stops came in the first 2 to 3 months.
From Saxenda prescribing information on DailyMed and Victoza prescribing information on DailyMed .
4.3% of adults stopped Wegovy because of these problems, compared with 0.7% on placebo.
In the Zepbound weight trials, 56% of adults on Zepbound and 30% on placebo had a stomach or bowel problem. 1.9% to 4.3% stopped Zepbound because of these problems, compared with 0.5% on placebo.
In the Mounjaro diabetes trials, 37.1% to 43.6% of adults on Mounjaro had a stomach or bowel problem, compared with 20.4% on placebo. 3.0% to 6.6% stopped Mounjaro because of them, compared with 0.4% on placebo.
From Mounjaro prescribing information on DailyMed and Zepbound prescribing information on DailyMed .
Each bar is one set of trials. The dots on this page come only from the time inside each bar.
Retatrutide, TRIUMPH-180 weeks
Retatrutide, TRIUMPH-280 weeks
Retatrutide, TRIUMPH-380 weeks
Trials can miss rare harms and harms that take years to appear.
Every number is copied from a table on our side effect pages. Those tables come from FDA labels on DailyMed, results posted on ClinicalTrials.gov, and company trial results. We did not add, total, or rank any number. Rows keep one fixed order: FDA-approved medicines first, then the rest, each in A to Z order.
We group rows by name. For example, “Tiredness (fatigue)” and “Tiredness or weakness (fatigue)” are both under tiredness. Each row still shows its own words from the source.
The tables on this site copy part of each label, such as the most common problems. A problem missing from one table may still have happened.
You can report a suspected side effect to the FDA at 1-800-FDA-1088 or through FDA MedWatch . If a reaction feels serious, get medical care first.